Pharming Group NV (OTCMKTS:PHGUF – Get Free Report)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $1.20, but opened at $1.30. Pharming Group shares last traded at $1.30, with a volume of 20,859 shares.
Pharming Group Trading Up 13.0%
The company has a market capitalization of $872.39 million, a PE ratio of 65.03 and a beta of 0.45. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.63 and a quick ratio of 2.06. The firm’s 50 day moving average is $1.33 and its 200 day moving average is $1.56.
Pharming Group (OTCMKTS:PHGUF – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $72.45 million during the quarter, compared to the consensus estimate of $92.06 million. Pharming Group had a return on equity of 4.64% and a net margin of 3.30%.
Pharming Group Company Profile
Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.
Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.
Featured Articles
- Five stocks we like better than Pharming Group
- 3 European Stocks to Carry Investors Through the Back Half of 2026
- Ouster Is Breaking Out as a Physical AI Leader: Here’s What’s Driving the Move
- Meta’s WhatsApp Shakeup Could Put India at the Center of Its Next Growth Push
- 3 Big Banks Plan Double Digit Dividend Increases After Passing Fed Stress Test
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
